Τίτλος:
Patient-reported outcomes (PROs) from IMvigor130: A global, randomised,
partially blinded phase III study of atezolizumab (atezo) plus
platinum-based chemotherapy (PBC) vs placebo (PBO) plus PBC in
previously untreated locally advanced or metastatic urothelial carcinoma
(mUC)
Συγγραφείς:
Bamias, A.
De Santis, M.
Arranz, J. A.
Grande, E. and
Galsky, M. D.
Kikuchi, E.
Park, S. H.
De Giorgi, U. and
Garcia del Muro, X.
Mencinger, M.
Alekseev, B.
Puente, J.
and Izumi, K.
Gumus, M.
Mellado Gonzalez, B.
Li, J-R. and
Quach, C.
Ding, B.
Bernhard, S.
Davis, I. D.
